Items where Author is "Wiliders, H."

Yes

Zaman, K. and Winterhalder, R. and Mamot, C. and Hasler-Strub, U. and Rochlitz, C. and Mueller, A. and Berset, C. and Wiliders, H. and Perey, L. and Rudolf, C. B. and Hawle, H. and Rondeau, S. and Neven, P.. (2015) Fulvestrant with or without selumetinib, a MEK 1/2 inhibitor, in breast cancer progressing after aromatase inhibitor therapy: A multicentre randomised placebo-controlled double-blind phase II trial, SAKK 21/08. European Journal of Cancer, 51 (10). pp. 1212-1220.